More than 1.2 million people in the United States have Human Immunodeficiency Virus
(HIV) infections but 13% of these people are unaware of their HIV infection. Current …

The inherent capacity of all organisms to evolve under selective pressure has created
multidrug-resistant microbes and cells that are now threatening decades of progress in …

In the early 2000s, novel humanized mouse models based on the transplantation of human
hematopoietic stem and progenitor cells (HSPCs) into immunocompromised mice were …

Emerging as a promising pathway to HIV vaccines, Virus-Like Particles (VLPs) have drawn
considerable attention in recent years. A challenge of working with HIV VLPs in …

Esculetin is a well-known coumarin derivative found abundantly in nature possessing an
extensive array of pharmacological and therapeutic properties. Consequently, to …

Despite being first identified more than three decades ago, the antisense gene asp of HIV-1
remains an enigma. asp is present uniquely in pandemic (group M) HIV-1 strains, and it is …

Extracellular vesicles (EVs), these minute yet mighty cellular messengers are redefining our
understanding of a spectrum of diseases, from cancer to cardiovascular ailments …

Human immunodeficiency virus (HIV) is a significant global health issue that affects a
substantial number of individuals across the globe, with a total of 39 million individuals living …

Despite advancements in vaccinology, there is currently no effective anti-HIV vaccine. One
strategy under investigation is based on the identification of epitopes recognized by broadly …

The human immunodeficiency virus (HIV) was first identified in 1983 and has since claimed
approximately 40.4 million lives worldwide (as of 2022). This number is staggering, and if left …